A Study to Assess the Effect of AF-219 on Cough Reflex Sensitivity in Both Healthy and Chronic Cough Subjects
Phase of Trial: Phase II
Latest Information Update: 21 Apr 2017
At a glance
- Drugs Gefapixant (Primary)
- Indications Cough
- Focus Therapeutic Use
- Acronyms Cough Challenge
- Sponsors Afferent Pharmaceuticals
- 07 Nov 2016 Status changed from active, no longer recruiting to completed.
- 06 Oct 2016 Planned End Date changed from 1 Sep 2016 to 1 Oct 2016.
- 06 Oct 2016 Status changed from recruiting to active, no longer recruiting.